Avivagen Inc. (TSXV:VIV), Bankruptcy

Avivagen Inc. (TSXV:VIV), an Ottawa, Ontario-based life sciences company which specialized in natural immune-boosting substances for pigs and cattle, filed an assignment in bankruptcy on April 23 listing $10.4 million in liabilities, including $6.1 million to Capital Transfer Agency and $2.9 million to Atlantic Canada Opportunities Agency.

Prior to the filing, the company conducted a strategic review process which culminated in a potential purchaser submitting a non-binding LOI. However, the deal failed to materialize and the company made the decision to file for bankruptcy.

BDO is the bankruptcy trustee.

By: Dina Milivojevic